---
schema_version: "secwatch.filing_event.v1"
accession: "0001477449-24-000099"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T07:50:40.899812+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Teladoc Health Q1 revenue +3% to $646.1M; adjusted EBITDA +20% to $63.1M

## Summary
- Revenue $646.1M (+3% YoY); net loss $81.9M ($0.49 EPS) vs $69.2M loss in Q1 2023.
- Integrated Care revenue +8% to $377.1M; BetterHelp revenue -4% to $269.0M.
- Adjusted EBITDA rose 20% to $63.1M; free cash flow -$26.6M (improved from -$32.5M).
- Q2 2024 outlook: revenue $635-660M, adj. EBITDA $70-80M, net loss per share ($0.45)-($0.35).
- Full-year 2024 outlook: revenue $2,635-2,735M, adj. EBITDA $350-390M, FCF $210-240M.

## SEC filing metadata
- accession: 0001477449-24-000099
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/0001477449-24-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/tdoc-20240425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477449-24-000099
- JSON: https://secwatch.observer/filing/0001477449-24-000099.json
- Plain text: https://secwatch.observer/filing/0001477449-24-000099.txt

## Key facts
- Earnings Releases
  Teladoc Health, Inc. reported three months ended March 31, 2024 results: revenue $646.1 million, net income $81.9 million net loss, EPS $0.49 per share. Guidance reaffirmed.
  - Period: three months ended March 31, 2024
  - Revenue: $646.1 million
  - Net income: $81.9 million net loss
  - EPS: $0.49 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: the three months ended March 31, 2023 (“First Quarter 2023”). Financial and Operational Highlights for First Quarter 2024 • First Quarter 2024 revenue grows 3% year-over-year to $646.1 million • First Quarter 2024 net loss of $81.9 million, or $0.49 per share • First Quarter 2024 adjusted EBITDA of $63.1 million, up 20% year-over-year “We are pleased to report a solid
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/0001477449-24-000099-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.